Novartis interacts with many patient groups. These groups play a crucial role by informing and supporting patients, as well as safeguarding the rights of patients and caregivers. Further, patient groups provide pharmaceutical companies with advice from an important perspective.

Interacting with patient organizations enables Novartis to learn about unmet patient needs, and this information can guide us in the development of new medicines. Novartis strives to provide patient groups with balanced, accurate and easy-to-understand scientific information about its available medicines.

We are committed to working with patient groups ethically and transparently while respecting their integrity. For optimum transparency, we disclose the names of patient groups in Europe, the US and international groups that have received funding or non-monetary support from Novartis during the first half of 2007. This list, which also includes professional organizations supporting or educating patients, will be updated at the beginning of each year.

Read our position on Patient group interaction and support ›